Shaoqing Zhou, MD
Urology · Annapolis, MDNPI 1003108549
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,000 of the $15,450 with a category attached, or 77.7%. Intuitive Surgical accounts for 86.4% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2023 at $13,621 and has fallen 95.1% since, to $667 in 2025.
Across 74 payments — averaging $208.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- Dendreon Pharmaceuticals LLC$251
- Sumitomo Pharma America, Inc.$249
- Urogen Pharma, Inc.$174
- Pfizer$152
- Axonics, Inc.$124
- plus $1K from 29 others
What the payments were for
- Travel & lodging$4473%
- Food & beverage$3,00219%
- Education$12,00078%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $13,347 |
| Dendreon Pharmaceuticals LLC | 2 | $251 |
| Sumitomo Pharma America, Inc. | 11 | $249 |
| Urogen Pharma, Inc. | 4 | $174 |
| Pfizer | 4 | $152 |
| Axonics, Inc. | 2 | $124 |
| Ferring Pharmaceuticals Inc. | 3 | $96 |
| Baxter Healthcare | 1 | $95 |
| Immunitybio, Inc. | 1 | $91 |
| Novo Nordisk | 1 | $83 |
| Astellas Pharma US Inc | 4 | $82 |
| Bayer | 3 | $74 |
| Coloplast | 1 | $68 |
| Myovant Sciences Inc. | 2 | $61 |
| Endo USA, Inc. | 3 | $53 |
| Progenics Pharmaceuticals, Inc. | 2 | $44 |
| Olympus America Inc. | 2 | $37 |
| Novartis | 1 | $30 |
| Tempus AI, Inc | 1 | $29 |
| Telix Pharmaceuticals | 1 | $27 |
| Urovant Sciences Inc | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $24 |
| Merck | 1 | $23 |
| Tolmar Pharmaceuticals, Inc. | 1 | $22 |
| Boston Scientific | 1 | $22 |
| Tolmar, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Accord Healthcare, Inc. | 1 | $17 |
| Calyxo, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Vertex | 1 | $14 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$13,335
- PROVENGE$251
How this compares
$15,450 in reported general payments places this provider in the 85th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 40 | $116,620 |
| GemtesaVibegron | 32 | $42,512 |
| Testosterone | 15 | $5,957 |
| Tamsulosin Hcl | 263 | $4,735 |
| Finasteride | 29 | $1,043 |
| NitrofurantoinNitrofurantoin Macrocrystal | 18 | $606 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $476 |
| CefuroximeCefuroxime Axetil | 50 | $199 |
| Levofloxacin | 26 | $81 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $63 |
| Ciprofloxacin Hcl | 30 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $249 | $159,13372 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 274 urology providers in Maryland.
Other urology in Annapolis
- Richard LevinAnnapolis$51K
- Juddson ChasonAnnapolis$20K
- James MastersonAnnapolis$14K
- Mara HoltonAnnapolis$13K
- Christopher GrazianoAnnapolis$12K
- Matthew AllawayCumberland$20.6M
- Benjamin LowentrittBaltimore$549K
- Julio DavalosGlen Burnie$490K
- Sankar KausikBel Air$375K
- Laura GiustoOwings Mills$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.